Heat killed cells of Cryptococcus neoformans var. grubii induces protective immunity in rats: immunological and histopathological parameters

References

• Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988; 157: 625–628
   Google Scholar
• Powderly WG. Therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1992; 14: 554–559
   Google Scholar
• Spitzer ED, Spitzer SG, Freundlich LF, Casadevall A. Persistence of the initial infection in recurrent cryptococcal meningitis. Lancet 1993; 341: 595–596
   PubMed Web of Science ®Google Scholar
• Bloomfield N, Gordon MA, Elmendorf DF., Jr. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc Soc Exp Biol Med 1963; 114: 64–67
   PubMed Web of Science ®Google Scholar
• Drouhet E, Segretain G. Inhibition of leukocyte migration in vitro by a capsular polyoside of Torulopsis (Cryptococcus) neoformans. Ann Inst Pasteur 1951; 81: 674–676
   PubMedGoogle Scholar
• Pettoello-Mantovani M, Casadevall A, Kollmann TR, Rubinstein A, Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 1992; 339: 21–23
   PubMed Web of Science ®Google Scholar
• Chiapello L, Baronetti J, Aoki P, et al. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology 2004; 113: 392–400
   PubMed Web of Science ®Google Scholar
• Murphy JW. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect Immun 1993; 61: 4750–4759
   PubMed Web of Science ®Google Scholar
• Flesch IEA, Schawamberger G, Kaufmann SHE. Fungicidal activity of INF-gamma-activated macrophages: extracellular killing of Cryptococcus neoformans. J Immunol 1989; 142: 3219–3224
   PubMedGoogle Scholar
• Levitz SM, DiBenedetto DJ. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun 1988; 56: 2544–2551
   PubMedGoogle Scholar
• Granger DL, Perfect JR, Durack DT. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol 1986; 136: 672–680
   PubMedGoogle Scholar
• Hill JO, Harmsen AG. Intrapulmonary growth and dissemination of an avirulent stain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J Exp Med 1991; 173: 755–758
   PubMed Web of Science ®Google Scholar
• Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319–326
   PubMed Web of Science ®Google Scholar
• Rossi GR, Cervi LA, Garcia MM, et al. Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis. Clin Immunol 1999; 90: 256–265
   PubMed Web of Science ®Google Scholar
• Rossi GR, Sastre DA, Rubinstein HR, Masih DT. Biochemical basis for the killing of Cryptococcus neoformans by rat peritoneal cells. J Med Vet Mycol 1994; 32: 405–414
   PubMedGoogle Scholar
• Bauman SK, Nichols KL, Murphy JW. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol 2000; 165: 158–167
   Google Scholar
• Cherniak R, Morris LC, Anderson BC, Meyer SA. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect Immun 1991; 59: 59–64
   PubMed Web of Science ®Google Scholar
• Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350–356
   Web of Science ®Google Scholar
• Rubinstein HR, Sotomayor CE, Cervi LA, Riera CM, Masih DT. Immunosuppression in experimental cryptococcosis in rats: Modification of macrophage functions by T suppressors cells. Mycopathologia 1989; 108: 11–19
   PubMedGoogle Scholar
• Goldman D, Lee S, Mednick A, Montella L, Casadevall A. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect Immun 2000; 68: 832–838
   PubMedGoogle Scholar
• Goldman D, Lee S, Casadevall A. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect Immun 1995; 63: 3448–3453
   PubMed Web of Science ®Google Scholar
• Goldman D, Lee S, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62: 4755–4761
   PubMed Web of Science ®Google Scholar
• Mukherjee J, Scharff MD, Casadevall A. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 1992; 60: 4534–4541
   PubMed Web of Science ®Google Scholar
• Rossi GR, Cervi LA, Sastre DA, Masih DT. Lack of involvement of nitric oxide in the macrophage-mediated inhibition of spleen cells proliferation during experimental cryptococcosis. Clin Immunol Immunopathol 1998; 86: 16–26
   Google Scholar
• Mody CH, Syme RM. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans. Infect Immun 1993; 61: 464–469
   PubMed Web of Science ®Google Scholar
• Caraher EM, Parenteau M, Gruber H, Scott FW. Flow cytometric analysis of intracellular IFN-gamma, IL-4 and IL-10 in CD3(+)4(+) T-cells from rat spleen. J Immunol Methods 2000; 244: 29–40
   PubMed Web of Science ®Google Scholar
• Stinn JL, Taylor MK, Becker G, et al. Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry. Am J Pathol 1998; 153: 1383–1392
   PubMed Web of Science ®Google Scholar
• Archer S. Measurement of nitric oxide in biological models. FASEB J 1993; 7: 349–360
   PubMed Web of Science ®Google Scholar
• McDonnell JM, Hutchins GM. Pulmonary cryptococcosis. Hum Pathol 1985; 16: 121–128
   Google Scholar
• Schneerson-Porat S, Shahar A, Aronson M. Formation of histiocyte rings in response to Cryptococcus neoformans infection. RES J Reticuloendothel Soc 1965; 2: 249–255
   Google Scholar
• Fromtling RA, Shadomy HJ. An overview of macrophage-fungal interactions. Mycopathología 1986; 93: 77–93
   PubMed Web of Science ®Google Scholar
• Hill JO. CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J Exp Med 1992; 175: 1685–1695
   PubMed Web of Science ®Google Scholar
• Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. Ann Intern Med 1974; 80: 176–181
   PubMed Web of Science ®Google Scholar
• Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci USA 2002; 99: 3165–3170
   PubMed Web of Science ®Google Scholar
• Aguirre K, Havell DA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63: 1725–1731
   PubMed Web of Science ®Google Scholar
• Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL12 and INF gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C. B-17 mice. Am J Respir Cell Mol Biol 1997; 17: 733–739
   PubMed Web of Science ®Google Scholar
• Kawakami K, Tohyama M, Qifeng X, Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun 1997; 65: 1307–1312
   PubMed Web of Science ®Google Scholar
• Janeway, CA, Travers, P. Immunobiology. The Immune System in Health and Disease. 2nd ed. New York: Garland Publishing Inc. 1996.
   Google Scholar
• Hidore MR, Nabavi N, Sonleitner F, Murphy JW. Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect Immun 1991; 59: 1747–1754
   Google Scholar
• CA Janeway, Travers, P, Walport, M, Capra, DJ, (eds). T-cell mediated immunity. In:. Immunobiology: The Immune System in Health and Disease, 4th ed, London: Elsevier, 1999; 263–305.
   Google Scholar
• Morani C, Retini C, Palazzetti B, Bistoni F, Vecchiarelli A. Regulatory role of exogenous IL10 in the development of immune response versus Cryptococcus neoformans. Clin Exp Immunol 1997; 109: 242–247
   Google Scholar
• Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98–106
   PubMed Web of Science ®Google Scholar
• Masih DT, Rubinstein HR, Sotomayor CE, Ferro ME, Riera CM. Non-specific immunosuppression in experimental cryptococcosis in rats. Mycopathol 1986; 94: 79–84
   Google Scholar
• Sotomayor CE, Rubinstein HR, Riera CM, Masih DT. Immunosuppression in experimental cryptococcosis in rats. Induction of afferent T suppressor cells to a non-related antigen. J Med Vet Mycol 1987; 65: 67–75
   Google Scholar
• Masih DT, Sotomayor CE, Rubinstein HR, Riera CM. Immunosuppression in experimental cryptococcosis in rats. Induction of efferent T suppressor cells to a non-related antigen. Mycopathol 1999; 144: 179–186
   Google Scholar
• Taniguchi M, Nakayama T. Recognition and function of Valpha14 NKT cells. Semin Immunol 2000; 12: 543–550
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21: 573–583
   PubMedGoogle Scholar
• Kawakami K, Kinjo Y, Yara S, et al. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun 2000; 69: 213–220
   Google Scholar
• Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS – 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1992; 8: 515–548
   Google Scholar
• Chaturvedi V, Wong B, Newman SL. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J Immunol 1996; 156: 3836–3840
   PubMed Web of Science ®Google Scholar
• Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 1991; 59: 2291–2296
   PubMedGoogle Scholar
• Yoshida K, Akaike T, Doi T, et al. Pronounced enhancement of.NO-dependent antimicrobial action by an.NO-oxidizing agent, imidazolineoxyl N-oxide. Infect Immun 1993; 61: 3552–3555
   PubMedGoogle Scholar
• Lovchik JA, Lyons CR, Lipscomb MF. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Respir Cell Mol Biol 1995; 13: 116–124
   PubMed Web of Science ®Google Scholar
• Lovchik J, Lipscomb M, Lyons CR. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J Immunol 1997; 158: 1772–1778
   Google Scholar
• Kawakami K. Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans. Jpn J Infect Dis 2004; 57: 137–145
   Google Scholar
• Rayhane N, Fitting C, Lortholary O, Dromer F, Cavaillon JM. Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun 2000; 68: 3748–3753
   Google Scholar
• Delfino D, Cianci L, Migliardo M, et al. Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect Immun 1996; 64: 5199–5204
   PubMed Web of Science ®Google Scholar
• Monari C, Bistoni F, Casadevall A, et al. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J Infect Dis 2005; 191: 127–137
   Google Scholar
• Murphy JW, Cozad GC. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun 1972; 5: 896–901
   PubMed Web of Science ®Google Scholar
• Retini C, Vecchiarelli A, Monari C, Bistoni F, Kozel TR. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect Immun 1998; 66: 664–669
   PubMedGoogle Scholar